|
"yen cj yen chia jui"的相關文件
顯示項目 1-3 / 3 (共1頁)
1
每頁顯示[10|25|50]項目
| 國立成功大學 |
2012-05-20 |
A phase I/II study of foretinib, an oral multikinase inhibitor targeting MET, RON, AXL, TIE-2, and VEGFR in advanced hepatocellular carcinoma (HCC).
|
Yau, TC (Yau, Thomas Cheung); Sukeepaisarnjaroen, W (Sukeepaisarnjaroen, Wattana); Chao, Y (Chao, Yee); Yen, CJ (Yen, Chia-Jui); Lausoontornsiri, W (Lausoontornsiri, Wirote); Chen, PJ (Chen, Pei-Jer); Sanpajit, T (Sanpajit, Theeranun); Lencioni, R (Lencioni, Riccardo); Camp, AC (Camp, Aaron C.); Cox, DS (Cox, Donna S.); Kallender, H (Kallender, Howard); Ottesen, LH (Ottesen, Lone Harild); Poon, RTP (Poon, Ronnie Tung-Ping) |
| 國立成功大學 |
2012-05 |
Phase Ib dose-escalation study of a phase II randomized trial to assess the safety and tolerability of tigatuzumab (CS-1008) in combination with sorafenib in patients (pts) with advanced hepatocellular carcinoma (HCC)
|
Cheng, AL (Cheng, Ann-Lii); Kang, YK (Kang, Yoon-Koo); Ryoo, BY (Ryoo, Baek-Yeol); Yen, CJ (Yen, Chia-Jui); Lim, HY (Lim, Ho Yeong); Oh, DY (Oh, Do-Youn); Austin, T (Austin, TaShara); Wang, Q (Wang, Qiang); Greenberg, J (Greenberg, Jonathan); Beckman, RA (Beckman, Robert A.); Kudo, M (Kudo, Masatoshi) |
| 亞洲大學 |
2008-08 |
Down-regulation of myeloid cell leukemia-1 through inhibiting Erk/Pin 1 pathway by sorafenib facilitates chemosensitization in breast cancer
|
Ding, QQ (Ding, Qingqing); Huo, LF (Huo, Longfei); Yang, JY (Yang, Jer-Yen); Xia, WY (Xia, Weiya); Wei, YK (Wei, Yongkun); Liao, Y (Liao, Yong); Chang, CJ (Chang, Chun-Ju); Yang, Y (Yang, Yan); Lai, CC (Lai, Chien-Chen); Lee, DF (Lee, Dung-Fang); Yen, CJ (Yen, Chia-Jui); Chen, YJR (Chen, Yun-Ju Rita); Hsu, JM (Hsu, Jung-Mao); Kuo, HP (Kuo, Hsu-Ping); Lin, CY (Lin, Chun-Yi); Tsai, FJ (Tsai, Fuu-Jen); Li, LY (Li, Long-Yuan); Tsai, CH (Tsai, Chang-Hai); Hung, MC (Hung, Mien-Chie) |
顯示項目 1-3 / 3 (共1頁)
1
每頁顯示[10|25|50]項目
|
